Stock Events

Stock Events

Cns Pharmaceuticals (BE50.F) Q4 2025 Earnings

14NovConfirmed

Q1 1

Q2 2025

Q3 2025

Q4 2025

-21.45

-15.58

-9.72

-3.86

Details

Expected EPS

-5.7037889999999996

Actual EPS

-4.955328

Surprise EPS

0.75

Surprise Percent

+13.12%

Description

Cns Pharmaceuticals (BE50.F) has reported earnings of -4.955328 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.